Choroideremia
Choroideremia is also known as total choroidal vascular atrophy, progressive choroidal atrophy or progressive tapetochorordal atrophy. It was first reported by Mauthner in 1872. Initially, the fundus manifestations were different from primary retinal degeneration, and it was considered to be the absence of the choroid. After long-term observation, it was found that the choroid and pigment epithelium were not congenitally dysplastic, but progressively disappeared after birth, so it is also called progressive RPE dystrophy degeneration or progressive RPE choroidal degeneration, but choroideremia is still used in custom. It is characterized by progressive onset of both eyes, night blindness since childhood, diffuse full-thickness choroidal capillaries and RPE atrophy, and finally complete disappearance of the choroid.
-
Site of disease:
Eye -
Infectious :
Not contagious -
Frequent population:
All groups -
Related symptoms:
visual impairment string pulse color vision abnormality tight pulse visual impairment -
Concurrent disease:
Related Drugs
Diclofenac Sodium
Indication: This product is suitable for the short-term treatment of the following acute pain: (1) pain and inflammation after trauma, such as foot sprains, muscle strains, etc. (2) pain and inflammation after surgery, such as dental or orthopedic surgery, etc. (3) gynecological pain and inflammation, such as primary dysmenorrhea or adnexitis, etc. (4) pain caused by spinal syndrome. (5) non-articular rheumatism. (6) severe infectious pain and inflammation of the ear, nose and throat (such as tonsillitis, otitis, sinusitis, etc.), which should be treated with anti-infective drugs at the same time.
Manufacturer:
Henan Dongtai Pharm Co., Ltd.
Related Ingredients